Back to Agenda
EMA Town Hall
Session Chair(s)
Steffen Thirstrup, MD, PhD
Chief Medical Officer
European Medicines Agency, Netherlands
The European Forum will explain our various platforms and ways to engage to support innovation, illustrated on an example of an Advanced Therapy Medicinal Product (ATMP).
Learning Objective : Describe the assessment procedure and the role of CHMP and rappoteur; Describe platforms to support developers; Discuss a successful submission of an ATMP.
Speaker(s)
Panelist
Sabine Haubenreisser, PhD, MSc
European Medicines Agency, Netherlands
Principal Scientific Administrator, Stakeholders and Communication Division
Panelist
Anabela Marcal, PharmD
European Medicines Agency, Netherlands
EMA Liaison Official to the US FDA
Panelist
Evdokia Korakianiti, PhD, MSc
European Medicines Agency, Netherlands
Head of Quality and Safety of Medicines
Have an account?